This buyer’s guide maps the Boehringer Ingelheim synthesis route, identifies four commercially critical intermediates with CAS numbers, explains why six chiral centers create six separate quality checkpoints.
This guide explains three formation pathways (amine + nitrite reaction, recovered solvent contamination, and shared-equipment cross-contamination), walks through the CPCA classification framework for assessing risk levels, and provides five questions every procurement team should ask their intermediate supplier — plus four red flags to spot on a COA.
A guide to LCZ696 intermediate synthesis: the five-step route, key quality control parameters, and co-crystal purity requirements for consistent API performance.
A practical sourcing guide for baricitinib intermediates covering the synthesis route, three key fragments, palladium removal quality checks, CoA verification red flags, market context, and the approaching patent expiry window.
Suzetrigine (Journavx) is the first non-opioid pain drug approved in 27 years. This guide covers its synthesis route, four chiral centers, key intermediates, and what buyers need to check before sourcing.
A practical sourcing guide for resmetirom intermediates covering the synthesis pathway, key building blocks, quality checkpoints, old vs new manufacturing routes, and the MASH drug supply chain outlook.
A practical step-by-step guide to shipping pharmaceutical intermediates from China, covering documentation, HS codes, packaging, freight methods, Incoterms, and customs clearance.
Leading provider of high-quality APIs and intermediates. Contact us for innovative solutions and expert support.